ATC code L01

ATC code L01 Antineoplastic agents is a therapeutic subgroup of the <a href="/facts/Anatomical_Therapeutic_Chemical_Classification_System/gcFTwqSA">Anatomical Therapeutic Chemical Classification System</a>, a system of alphanumeric codes developed by the <a href="/facts/World_Health_Organization/YNN3bgug">World Health Organization</a> (WHO) for the classification of <a href="/facts/Pharmaceutical_drug/h9mhwWP2">drugs</a> and other medical products. Subgroup L01 is part of the anatomical group <a href="/facts/ATC_code_L/nfBwsYMW">L Antineoplastic and immunomodulating agents</a>.
Codes for <a href="/facts/Veterinary/KYNaodgl">veterinary</a> use (<a href="/facts/ATCvet_code/gcFTwqSA">ATCvet codes</a>) can be created by placing the letter Q in front of the human ATC code: for example, QL01. ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

ATC code L01 open-in-new

ATC code L01